MRI for detection, staging, and follow-up of prostate cancer: Synthesis of the PI-RADS v2.1, MET-RADS, PRECISE, and PI-RR guidelines

J C Vilanova; V Catalá-Sventzetzky; J Hernández-Mancera

doi:10.1016/j.rxeng.2022.12.005

MRI for detection, staging, and follow-up of prostate cancer: Synthesis of the PI-RADS v2.1, MET-RADS, PRECISE, and PI-RR guidelines

Radiologia (Engl Ed). 2023 Sep-Oct;65(5):431-446. doi: 10.1016/j.rxeng.2022.12.005. Epub 2023 Jun 29.

Authors

J C Vilanova¹, V Catalá-Sventzetzky², J Hernández-Mancera³

Affiliations

¹ Departamento Radiología, Clínica Girona, Institut de Diagnòstic per la Imatge (IDI), Hospital Dr. J. Trueta/Hospital Sta. Caterina, Departamento de Ciencias Médicas, Facultad de Medicina, Universitat de Girona, Girona, Spain. Electronic address: kvilanova@comg.cat.
² Unidad de Uroradiología, Creu Blanca, Uroima, Barcelona, Spain.
³ Servicio de Radiología, Fundació Puigvert, Creu Blanca, Barcelona, Spain.

PMID: 37758334
DOI: 10.1016/j.rxeng.2022.12.005

Abstract

Prostate cancer is very common among men. Radiology, mainly through MRI, plays a key role in the different stages of prostate cancer: diagnosis, staging and treatment assessment. The correct management of MRI requires knowledge and proper use of the different guidelines developed for the acquisition, interpretation and reporting of MRI in diagnosis (PI-RADS guide), whole body staging (MET-RADS guide), active surveillance (PRECISE guide) and local recurrence (PI-RR guide) in prostate cancer. The objective of this article is to show an update and synthesis of the most relevant aspects of these MRI guidelines for an optimal use and thus providing a more effective management of prostate cancer.

Keywords: Cáncer de próstata; Estadificación; Guía estandarizada; Magnetic resonance; Prostate cancer; Resonancia magnética; Staging; Standardization.